search URL:,https://patents.google.com/?assignee=BLUEPRINT+MEDICINES+CORP
id,title,assignee,inventor/author,priority date,filing/creation date,publication date,grant date,result link,representative figure link
US-9126951-B2,Inhibitors of the fibroblast growth factor receptor ,Blueprint Medicines Corporation,"Neil Bifulco, JR., Natasja Brooijmans, Brian L. Hodous, Joseph L. Kim, Chandrasekhar V. Miduturu",2012-07-11,2014-06-27,2015-09-08,2015-09-08,https://patents.google.com/patent/US9126951B2/en,https://patentimages.storage.googleapis.com/11/a2/34/a774a843ad3c71/US09126951-20150908-D00001.png
US-9695165-B2,Inhibitors of the fibroblast growth factor receptor ,Blueprint Medicines Corporation,"Neil Bifulco, JR., Lucian V. DiPietro, Chandrasekhar V. Miduturu",2014-01-15,2015-01-14,2017-07-04,2017-07-04,https://patents.google.com/patent/US9695165B2/en,
US-9434700-B2,Inhibitors of the fibroblast growth factor receptor ,"Neil Bifulco, JR., Lucian V. DiPietro, Brian L. Hodous, Chandrasekhar V. Miduturu","Neil Bifulco, JR., Lucian V. DiPietro, Brian L. Hodous, Chandrasekhar V. Miduturu",2013-10-25,2014-10-23,2016-09-06,2016-09-06,https://patents.google.com/patent/US9434700B2/en,https://patentimages.storage.googleapis.com/04/06/b8/3f60e18a287c5d/US09434700-20160906-D00001.png
US-9499522-B2,Compositions useful for treating disorders related to kit ,Blueprint Medicines Corporation,"Lucian V. DiPietro, Brian L. Hodous, Joseph L. Kim, Chandrasekhar V. Miduturu, Steven Mark Wenglowsky, Douglas Wilson, Yulian Zhang",2013-03-15,2014-03-14,2016-11-22,2016-11-22,https://patents.google.com/patent/US9499522B2/en,
EP-3057969-B1,Compositions useful for treating disorders related to kit ,Blueprint Medicines Corporation,"Yulian Zhang, Brian L. Hodous, Joseph L. Kim, Kevin J. Wilson, Douglas Wilson",2013-10-17,2014-10-15,2018-06-13,2018-06-13,https://patents.google.com/patent/EP3057969B1/en,https://patentimages.storage.googleapis.com/5c/ba/04/299feffe408a35/imgf0001.png
US-9334263-B2,Compositions useful for treating disorders related to kit ,Blueprint Medicines Corporation,"Brian L. Hodous, Joseph L. Kim, Chandrasekhar V. Miduturu, Douglas Wilson, Yulian Zhang",2013-10-17,2014-10-17,2016-05-10,2016-05-10,https://patents.google.com/patent/US9334263B2/en,https://patentimages.storage.googleapis.com/86/0d/c9/71b46ecbf3fc64/US09334263-20160510-D00001.png
US-9688680-B2,Compositions useful for treating disorders related to kit ,Blueprint Medicines Corporation,Brian L. Hodous,2014-08-04,2015-08-04,2017-06-27,2017-06-27,https://patents.google.com/patent/US9688680B2/en,
US-2014187559-A1,Inhibitors of the fibroblast growth factor receptor ,Blueprint Medicines Corporation,Chandrasekhar V. Miduturu,2012-12-28,2013-12-26,2014-07-03,,https://patents.google.com/patent/US20140187559A1/en,https://patentimages.storage.googleapis.com/40/e7/da/0618ec020723bc/US20140187559A1-20140703-D00001.png
US-2016272725-A1,Ntrk2 fusions ,Blueprint Medicines Corporation,"Nicolas Stransky, Ethan G. CERAMI, Christoph Lengauer",2013-07-30,2014-07-30,2016-09-22,,https://patents.google.com/patent/US20160272725A1/en,https://patentimages.storage.googleapis.com/6b/72/ef/a026b5e47d11f3/US20160272725A1-20160922-D00001.png
US-10030005-B2,Inhibitors of RET ,Blueprint Medicines Corporation,"Jason D. Brubaker, Joseph L. Kim, Kevin J. Wilson, Douglas Wilson, Lucian V. DiPietro",2015-11-02,2016-11-01,2018-07-24,2018-07-24,https://patents.google.com/patent/US10030005B2/en,
US-10183928-B2,Inhibitors of RET ,Blueprint Medicines Corporation,"Joseph L. Kim, Kevin J. Wilson, Jason D. Brubaker",2016-03-17,2017-03-17,2019-01-22,2019-01-22,https://patents.google.com/patent/US10183928B2/en,
US-10202365-B2,2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors ,Blueprint Medicines Corporation,"Natasja Brooijmans, Lucian V. DiPietro, Paul E. Fleming, Joseph L. Kim, Steven Mark Wenglowsky, Yulian Zhang",2015-02-06,2016-02-05,2019-02-12,2019-02-12,https://patents.google.com/patent/US10202365B2/en,
US-10000496-B2,Compositions useful for treating disorders related to kit and PDGFR ,Blueprint Medicines Corporation,"Brian L. Hodous, Kevin J. Wilson, Yulian Zhang",2015-07-24,2016-07-22,2018-06-19,2018-06-19,https://patents.google.com/patent/US10000496B2/en,
US-2016251446-A1,Pik3c2g fusions ,Blueprint Medicines Corporation,"Nicolas Stransky, Ethan G. CERAMI, Joseph L. Kim, Christoph Lengauer",2013-07-30,2014-07-30,2016-09-01,,https://patents.google.com/patent/US20160251446A1/en,https://patentimages.storage.googleapis.com/7d/29/58/6535d04f0ba5ad/US20160251446A1-20160901-D00001.png
EP-3169804-B1,Fgr fusions ,Blueprint Medicines Corporation,"Ethan G. CERAMI, Nicolas Stransky",2014-07-17,2015-07-15,2019-01-30,2019-01-30,https://patents.google.com/patent/EP3169804B1/en,https://patentimages.storage.googleapis.com/79/8b/78/0a33d528002cea/imgf0001.png
US-10233186-B2,Inhibitors of activin receptor-like kinase ,Blueprint Medicines Corporation,"Natasja Brooijmans, Jason D. Brubaker, Mark Cronin, Paul E. Fleming, Brian L. Hodous, Joseph L. Kim, Brett Williams, Douglas Wilson, Kevin J. Wilson",2016-04-15,2017-04-14,2019-03-19,2019-03-19,https://patents.google.com/patent/US10233186B2/en,
US-10246750-B2,Method for detection of a TECR:PKN1 or an ANXA4:PKN1 gene fusion ,Blueprint Medicines Corporation,"Nicolas Stransky, Joseph L. Kim",2014-06-10,2015-06-10,2019-04-02,2019-04-02,https://patents.google.com/patent/US10246750B2/en,https://patentimages.storage.googleapis.com/e1/6b/3a/d02902e781290d/US10246750-20190402-D00001.png
US-10017512-B2,Compounds and compositions useful for treating disorders related to NTRK ,Blueprint Medicines Corporation,"Steven Mark Wenglowsky, Natasja Brooijmans, Chandrasekhar V. Miduturu, Neil Bifulco, JR.",2015-08-26,2016-08-26,2018-07-10,2018-07-10,https://patents.google.com/patent/US10017512B2/en,https://patentimages.storage.googleapis.com/16/af/13/a0ff95f3a55e70/US10017512-20180710-D00001.png
US-2017044622-A1,Pik3ca fusions ,Blueprint Medicines Corporation,"Ethan G. CERAMI, Christoph Lengauer, Nicolas Stransky",2014-04-18,2015-04-17,2017-02-16,,https://patents.google.com/patent/US20170044622A1/en,https://patentimages.storage.googleapis.com/5c/11/71/5196e398ace8b5/US20170044622A1-20170216-D00001.png
US-2017044621-A1,Met fusions ,Blueprint Medicines Corporation,"Ehan G. Cerami, Christoph Lengauer, Nicolas Stransky",2014-04-18,2015-04-17,2017-02-16,,https://patents.google.com/patent/US20170044621A1/en,https://patentimages.storage.googleapis.com/69/09/2f/01a5a05507eb63/US20170044621A1-20170216-D00001.png
WO-2017087778-A1,Compounds and compositions useful for treating disorders related to ntrk ,Blueprint Medicines Corporation,"Steven Mark WENGLOWSKY, Chandrasekhar V. MIDUTURU, Neil Bifulco, Jr, Joseph L. Kim",2015-11-19,2016-11-18,2017-05-26,,https://patents.google.com/patent/WO2017087778A1/en,
EP-3169808-B1,Trio:tert fusion in cancer ,Blueprint Medicines Corporation,Nicolas Stransky,2014-07-17,2015-07-15,2019-05-22,2019-05-22,https://patents.google.com/patent/EP3169808B1/en,https://patentimages.storage.googleapis.com/be/2b/66/83302e70a27838/imgf0001.png
US-2017356052-A1,Prkacb fusions ,Blueprint Medicines Corporation,Nicolas Stransky,2014-11-18,2015-11-17,2017-12-14,,https://patents.google.com/patent/US20170356052A1/en,https://patentimages.storage.googleapis.com/05/55/29/fe3f07da85d15c/US20170356052A1-20171214-D00001.png
US-2017211148-A1,Prkc fusions ,Blueprint Medicines Corporation,"Nicolas Stransky, Joseph L. Kim",2014-07-17,2015-07-15,2017-07-27,,https://patents.google.com/patent/US20170211148A1/en,https://patentimages.storage.googleapis.com/bd/e7/35/729cc39c910cc5/US20170211148A1-20170727-D00001.png
US-2017137889-A1,Raf1 fusions ,Blueprint Medicines Corporation,"Nicolas Stransky, Joseph L. Kim",2014-06-10,2015-06-10,2017-05-18,,https://patents.google.com/patent/US20170137889A1/en,https://patentimages.storage.googleapis.com/bc/03/db/e325967a83a86f/US20170137889A1-20170518-D00001.png
US-10035789-B2,Compounds useful for treating disorders related to RET ,Blueprint Medicines Corporation,"Jason D. Brubaker, Lucian V. DiPietro",2016-07-27,2017-07-26,2018-07-31,2018-07-31,https://patents.google.com/patent/US10035789B2/en,
US-10227329-B2,Compounds useful for treating disorders related to RET ,Blueprint Medicines Corporation,"Jason D. Brubaker, Timothy Guzi, Kevin J. Wilson, Lucian V. DiPietro, Yulian Zhang, Douglas Wilson, Paul E. Fleming",2016-07-22,2017-07-21,2019-03-12,2019-03-12,https://patents.google.com/patent/US10227329B2/en,
US-773481-A,Paper basket. ,James F Donley,James F Donley,1903-04-11,1903-04-11,1904-10-25,1904-10-25,https://patents.google.com/patent/US773481A/en,https://patentimages.storage.googleapis.com/b6/a4/96/c3cad038c28aa1/US773481-drawings-page-1.png
US-2019169194-A1,Compounds and compositions useful for treating disorders related to ntrk ,Blueprint Medicines Corporation,"Steven Mark Wenglowsky, Natasja Brooijmans, Chandrasekhar V. Miduturu, Neil Bifulco, JR.",,2018-07-03,2019-06-06,,https://patents.google.com/patent/US20190169194A1/en,https://patentimages.storage.googleapis.com/96/67/a2/8d0142f0fb3949/US20190169194A1-20190606-D00001.png
AR-106548-A1,Ret inhibitors ,Blueprint Medicines Corp,"V Dpietro Lucian, Wilson Douglas, J Wilson Kevin, L Kim Joseph, D Brubaker Jason",2015-11-02,2016-11-01,2018-01-24,,https://patents.google.com/patent/AR106548A1/en,
WO-2019079649-A1,Substituted pyrrolopyridines as inhibitors of activin receptor-like kinase ,Blueprint Medicines Corporation,"Jason D. Brubaker, Paul E. Fleming, Joseph L. Kim, Brett Williams, Brian L. Hodous",2017-10-18,2018-10-18,2019-04-25,,https://patents.google.com/patent/WO2019079649A1/en,
AR-098054-A1,compounds useful for treating disorders related kit ,Blueprint Medicines Corp,"L Kim Joseph, Wilson Douglas, Zhang Yulian, L Hodous Brian, J Wilson Kevin",2013-10-17,2014-10-16,2016-04-27,,https://patents.google.com/patent/AR098054A1/en,
WO-2018183712-A1,"Pyrrolo[1,2-b]pyridazine compounds and compositions useful for treating disorders related to kit and pdgfr ",Blueprint Medicines Corporation,"Brian L. Hodous, Joseph L. Kim, Kevin J. Wilson",2017-03-31,2018-03-29,2018-10-04,,https://patents.google.com/patent/WO2018183712A1/en,
AR-098185-A1,Receptor inhibitors of fibroblast growth factor ,Blueprint Medicines Corp,"Bifulco Neil Jr, V Dpietro Lucian, L Hodous Brian, V Miduturu Chandrasekhar",2013-10-25,2014-10-24,2016-05-18,,https://patents.google.com/patent/AR098185A1/en,
WO-2018213329-A1,Combinations of ret inhibitors and mtorc1 inhibitors and uses thereof for the treatment of cancer mediated by aberrant ret activity ,Blueprint Medicines Corporation,"Erica Evans RAAB, Rami RAHAL",2017-05-15,2018-05-15,2018-11-22,,https://patents.google.com/patent/WO2018213329A1/en,
